Bifico relieves irritable bowel syndrome by regulating gut microbiota dysbiosis and inflammatory cytokines

PURPOSE: Gut microbiota dysbiosis, a core pathophysiology of irritable bowel syndrome (IBS), is closely related to immunological and metabolic functions. Gut microbiota-based therapeutics have been recently explored in several studies. Bifico is a probiotic cocktail widely used in gastrointestinal d...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Yanlin, Zhang, Fan, Mao, Liqi, Feng, Tongfei, Wang, Kaijie, Xu, Maosheng, Lv, Bin, Wang, Xi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Original Contribution
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9899748/
https://www.ncbi.nlm.nih.gov/pubmed/35918555
http://dx.doi.org/10.1007/s00394-022-02958-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9899748/
https://www.ncbi.nlm.nih.gov/pubmed/35918555
http://dx.doi.org/10.1007/s00394-022-02958-0

Ejemplares similares